BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 7, Issue 6
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (18122)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.
Item 
Count 
PDF1067
WORD471
HTML11232
Figures (1-3)279
Tables (1-2)231
 Sum=13280
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse680
Download1164
 Sum=1844
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1368
Download1630
 Sum=2998
Apr 28, 2015 (publication date) through Dec 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Echeverría N, Moratorio G, Cristina J, Moreno P. Hepatitis C virus genetic variability and evolution. World J Hepatol 2015; 7(6): 831-845 [PMID: 25937861 DOI: 10.4254/wjh.v7.i6.831]
URL: https://www.wjgnet.com/1948-5182/full/v7/i6/831.htm
Number Citing Articles
1
Lanhui Yang, Chenyan Jiang, Song Hu, Qiongni Diao, Jia Li, Wei Si, Mei Chen, Richard Zhao. Evolving Diversity of Hepatitis C Viruses in Yunnan Honghe, China. International Journal of Molecular Sciences 2016; 17(3): 403 doi: 10.3390/ijms17030403
2
Václav Vopálenský, Anas Khawaja, Luděk Rožnovský, Jakub Mrázek, Tomáš Mašek, Martin Pospíšek. Characterization of Hepatitis C Virus IRES Quasispecies – From the Individual to the Pool. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00731
3
Asma Ahsan, Saira Dar, Fareeha Hassan, Farkhanda Ghafoor, Muhammad Haroon Yousuf, Syed Shahzad-ul-Hussan, Sripathi M Sureban. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus. PLOS ONE 2021; 16(8): e0256816 doi: 10.1371/journal.pone.0256816
4
Satoshi Kokura. Hyperthermic Oncology from Bench to Bedside. 2016; : 261 doi: 10.1007/978-981-10-0719-4_25
5
Evelyn Stelzl, Bernhard Haas, Bernd Bauer, Sherry Zhang, Ellen H. Fiss, Grantland Hillman, Aaron T. Hamilton, Rochak Mehta, Marintha L. Heil, Ed G. Marins, Brigitte I. Santner, Harald H. Kessler, Heiner Wedemeyer. First identification of a recombinant form of hepatitis C virus in Austrian patients by full-genome next generation sequencing. PLOS ONE 2017; 12(7): e0181273 doi: 10.1371/journal.pone.0181273
6
Nikolai Bessonov, Gennady Bocharov, Andreas Meyerhans, Vladimir Popov, Vitaly Volpert. Existence and Dynamics of Strains in a Nonlocal Reaction-Diffusion Model of Viral Evolution. SIAM Journal on Applied Mathematics 2021; 81(1): 107 doi: 10.1137/19M1282234
7
Mohamed El-Mesery, Mohammed El-Mowafy, Abdelaziz Elgaml, Laila F. Youssef, Sally Y. Abed. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients. Journal of Interferon & Cytokine Research 2017; 37(8): 342 doi: 10.1089/jir.2016.0128
8
Ilan S. Weisberg, Ira M. Jacobson. Primer on Hepatitis C Virus Resistance to Direct-Acting Antiviral Treatment. Clinics in Liver Disease 2017; 21(4): 659 doi: 10.1016/j.cld.2017.06.007
9
Ali Moussaoui, Vitaly Volpert. The influence of immune cells on the existence of virus quasi-species. Mathematical Biosciences and Engineering 2023; 20(9): 15942 doi: 10.3934/mbe.2023710
10
Jun-Kyu Lee, Ji-Wan Choi, InWha Park, Na-Eun Kim, Hak Cheol Kwon, Jaeyoung Kwon, Yoon-Jae Song. Roseoside Is a Bioactive Compound in Kirengeshoma koreana Nakai Extract with Potent In Vitro Antiviral Activity Against Hepatitis C Virus. Molecules 2024; 29(21): 5130 doi: 10.3390/molecules29215130
11
Melina Farshbafnadi, Nima Rezaei. Handbook of Cancer and Immunology. 2024; : 1 doi: 10.1007/978-3-030-80962-1_125-1
12
Ana Ortega-Prieto, Marcus Dorner. Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection. Vaccines 2017; 5(3): 24 doi: 10.3390/vaccines5030024
13
Daniele Lapa, Anna Rosa Garbuglia, Maria Rosaria Capobianchi, Paola Del Porto. Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?. Cells 2019; 8(4): 305 doi: 10.3390/cells8040305
14
Waqas Gulzar, Zafar Niaz, Sami Ullah Mumtaz, Somia Iqtadar, Tayyeba Komal, Sajid AbaidUllah. Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3a. Pakistan BioMedical Journal 2019; 2(1) doi: 10.52229/pbmj.v2i1.28
15
Elisabetta Loggi, Ranka Vukotic, Fabio Conti, Stefano Gitto, Pietro Andreone. Gold Standard Assays for the Monitoring of Patients With Chronic Hepatitis C. Future Virology 2018; 13(8): 529 doi: 10.2217/fvl-2018-0032
16
Natalia Echeverría, Fabiana Gámbaro, Stéphanie Beaucourt, Martín Soñora, Nelia Hernández, Juan Cristina, Gonzalo Moratorio, Pilar Moreno. Mixed Infections Unravel Novel HCV Inter-Genotypic Recombinant Forms within the Conserved IRES Region. Viruses 2024; 16(4): 560 doi: 10.3390/v16040560
17
Pauline Trémeaux, Alban Caporossi, Marie-Ange Thélu, Michael Blum, Vincent Leroy, Patrice Morand, Sylvie Larrat. Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges. Critical Reviews in Clinical Laboratory Sciences 2016; 53(5): 341 doi: 10.3109/10408363.2016.1163663
18
Dimas Alexandre Kliemann, Cristiane Valle Tovo, Ana Beatriz Gorini da Veiga, Angelo Alves de Mattos, Charles Wood. Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database. World Journal of Gastroenterology 2016; 22(40): 8910-8917 doi: 10.3748/wjg.v22.i40.8910
19
Andrea Galli, Jens Bukh. Viral Fitness and Evolution. Current Topics in Microbiology and Immunology 2023; 439: 237 doi: 10.1007/978-3-031-15640-3_7
20
Caroline E. R. Rowell, Hana M. Dobrovolny. Energy Requirements for Loss of Viral Infectivity. Food and Environmental Virology 2020; 12(4): 281 doi: 10.1007/s12560-020-09439-9
21
Kaho H. Tisthammer, Weiyan Dong, Jeffrey B. Joy, Pleuni S. Pennings. Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3a. Viruses 2021; 13(3): 511 doi: 10.3390/v13030511
22
Nian Ma, Dipayan Bose, Erle S. Robertson. Reference Module in Biomedical Sciences. 2024;  doi: 10.1016/B978-0-323-95488-4.00114-5
23
Ahmed A. Ali, Ashraf A. Tabll. Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development. Virology 2025; 602: 110307 doi: 10.1016/j.virol.2024.110307
24
Mengdi Qi, Mengmei Yang, Liangzi Xu, Chunli Ma, Pu Huang, Jing Sun, Jiandong Shi, Yunzhang Hu. Complete genome analysis identifies recombinant events and positive selection sites of hepatitis C virus from mainland China during 2010–2019. Virus Research 2021; 296: 198354 doi: 10.1016/j.virusres.2021.198354
25
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno, Juan Cristina. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World Journal of Hepatology 2021; 13(10): 1234-1268 doi: 10.4254/wjh.v13.i10.1234
26
Micaela Parra, Natalia Laufer, Julieta M. Manrique, Leandro R. Jones, Jorge Quarleri. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1728456
27
Rabaa Y. Athamneh, Rawan Abudalo, Malik Sallam, Abdelrahim Alqudah, Hasan Alquran, Kawther Faisal Amawi, Hashem A. Abu-Harirah. Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes. Infection, Genetics and Evolution 2023; 109: 105412 doi: 10.1016/j.meegid.2023.105412
28
Asad Zia, Muhammad Ali, Hafsa Aziz, Muhammad Zia, Zabta Khan Shinwari, Abida Raza. A case of a patient infected with a hepatitis C virus genotype 3a multidrug resistant variant in Pakistan. Infectious Diseases of Poverty 2018; 7(1) doi: 10.1186/s40249-018-0386-7
29
Mohammad Amin Behzadi, Abdolvahab Alborzi, Gholamreza Pouladfar, Mehdi Dianatpour, Mazyar Ziyaeyan. Expression of NS3/NS4A Proteins of Hepatitis C Virus in Huh7 Cells Following Engineering Its Eukaryotic Expression Vector. Jundishapur Journal of Microbiology 2015; 8(11) doi: 10.5812/jjm.27355
30
Bushra Khubaib, Muhammad Idrees, Zareen Fatima, Madiha Akram, Samia Afzal, Iram Amin, Muhammad Shahid, Muhammad Wasim. Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome. Journal of Digestive Diseases 2017; 18(7): 404 doi: 10.1111/1751-2980.12497
31
Lily He, Rui Dong, Rong Lucy He, Stephen S.-T. Yau. Positional Correlation Natural Vector: A Novel Method for Genome Comparison. International Journal of Molecular Sciences 2020; 21(11): 3859 doi: 10.3390/ijms21113859
32
Miguel Angel Martinez, Sandra Franco. Antiviral Drug Discovery and Development. Advances in Experimental Medicine and Biology 2021; 1322: 139 doi: 10.1007/978-981-16-0267-2_6
33
Dana Elkhalifa, Israa Al-Hashimi, Ala-Eddin Al Moustafa, Ashraf Khalil. A comprehensive review on the antiviral activities of chalcones. Journal of Drug Targeting 2021; 29(4): 403 doi: 10.1080/1061186X.2020.1853759
34
Mohammed El-Mowafy, Abdelaziz Elgaml, Mohamed El-Mesery, Salma Sultan, Tamer A. E. Ahmed, Ahmed I. Gomaa, Mahmoud Aly, Walid Mottawea. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection. Biology 2021; 10(1): 55 doi: 10.3390/biology10010055
35
Miguel A. Minaya, Travis L. Jensen, Johannes B. Goll, Maria Korom, Sree H. Datla, Robert B. Belshe, Lynda A. Morrison, Richard M. Longnecker. Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections. Journal of Virology 2017; 91(23) doi: 10.1128/JVI.00942-17
36
Juliana Cristina Santiago Bastos, Marina Aiello Padilla, Leonardo Cardia Caserta, Noelle Miotto, Aline Gonzalez Vigani, Clarice Weis Arns. Hepatitis C virus: Promising discoveries and new treatments. World Journal of Gastroenterology 2016; 22(28): 6393-6401 doi: 10.3748/wjg.v22.i28.6393
37
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology. 2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
38
Seema Patel. In silico analysis of Hepatitis C virus (HCV) polyprotein domains and their comparison with other pathogens and allergens to gain insight on pathogenicity mechanisms. Computational Biology and Chemistry 2016; 65: 91 doi: 10.1016/j.compbiolchem.2016.10.006
39
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman. BMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
40
P. Muñoz de Rueda, S. M. Jiménez-Ruiz, R. Quiles, E. J. Pavón-Castillero, J. A. Muñoz-Gámez, J. Casado, A. Gila, A. Ruiz-Extremera, J. Salmerón. The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15605-0
41
Shantanu Prakash, Suruchi Shukla, Vangala Ramakrishna, Amita Jain. Distribution of hepatitis C genotypes in Uttar Pradesh, India; rare genotype 4 detected. Journal of Medical Virology 2018; 90(12): 1875 doi: 10.1002/jmv.25277
42
Hisashi Nakayama, Tadatoshi Takayama. Management before hepatectomy for hepatocellular carcinoma with cirrhosis. World Journal of Hepatology 2015; 7(20): 2292-2302 doi: 10.4254/wjh.v7.i20.2292
43
Luis E. Gomez-Quiroz, Sonia Roman. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico. Annals of Hepatology 2022; 27: 100649 doi: 10.1016/j.aohep.2021.100649
44
Anton Eliseev, Keylie M. Gibson, Pavel Avdeyev, Dmitry Novik, Matthew L. Bendall, Marcos Pérez-Losada, Nikita Alexeev, Keith A. Crandall. Evaluation of haplotype callers for next-generation sequencing of viruses. Infection, Genetics and Evolution 2020; 82: 104277 doi: 10.1016/j.meegid.2020.104277
45
Wei Zhan, Manish Muhuri, Phillip W. L. Tai, Guangping Gao. Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.673699
46
Afshin A. Anoushiravani, Gokul Kalyanasundaram, James E. Feng, Frank Congiusta, Richard Iorio, Matthew R. DiCaprio. Treating Hepatitis C Prior to Total Hip Arthroplasty is Cost-effective: A Markov Analysis. The Journal of Arthroplasty 2023; 38(7): S84 doi: 10.1016/j.arth.2023.02.067
47
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023; 15(1): 214 doi: 10.3390/v15010214
48
Kimia Kamelian, Vincent Montoya, Andrea Olmstead, Winnie Dong, Richard Harrigan, Muhammad Morshed, Jeffrey B. Joy. Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methods. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52613-8
49
Joel Henrique Ellwanger, Valéria de Lima Kaminski, Jacqueline María Valverde-Villegas, Daniel Simon, Vagner Ricardo Lunge, José Artur Bogo Chies. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming. Infection, Genetics and Evolution 2018; 66: 376 doi: 10.1016/j.meegid.2017.08.011
50
Letitia Shunmugam, Mahmoud E. S. Soliman. Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition. RSC Advances 2018; 8(73): 42210 doi: 10.1039/C8RA07346E
51
Chin Pok Chan, Haruka Uemura, Tsz Ho Kwan, Ngai Sze Wong, Shinichi Oka, Denise Pui Chung Chan, Shui Shan Lee. Review on the molecular epidemiology of sexually acquired hepatitis C virus infection in the Asia‐Pacific region. Journal of the International AIDS Society 2020; 23(9) doi: 10.1002/jia2.25618
52
Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2023; : 1 doi: 10.2174/9789815123432123010004
53
Noriyuki Watanabe, Takaya Suzuki, Tomoko Date, Hussein Aly Hussan, Su Su Hmwe, Hideki Aizaki, Masaya Sugiyama, Masashi Mizokami, William Delaney IV, Guofeng Cheng, Masamichi Muramatsu, Takaji Wakita. Establishment of infectious genotype 4 cell culture-derived hepatitis C virus. Journal of General Virology 2020; 101(2): 188 doi: 10.1099/jgv.0.001378
54
Luis Antonio Uribe-Noguez, José Antonio Mata-Marín, Alicia Ocaña-Mondragón, Ericka Nelly Pompa-Mera, Rosa María Ribas-Aparicio, Carla Ileana Arroyo-Anduiza, María Elena Gomez-Torres, Alberto Chaparro-Sánchez, Jesus Gaytán-Martínez, Stefan Mauss. Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico. Journal of Infection and Chemotherapy 2020; 26(2): 205 doi: 10.1016/j.jiac.2019.08.009
55
Mohamed El-Mesery, Mohammed El-Mowafy, Laila F. Youssef, Ahmed El-Mesery, Sally Yussef Abed, Abdelaziz Elgaml. Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients. Journal of Interferon & Cytokine Research 2021; 41(2): 52 doi: 10.1089/jir.2020.0118
56
Sobia Manzoor, Umair Akhtar, Sidrah Naseem, Madiha Khalid, Misha Mazhar, Fahed Parvaiz, Saba Khaliq. Ionotropic Purinergic Receptors P2X4 and P2X7: Proviral or Antiviral? An Insight into P2X Receptor Signaling and Hepatitis C Virus Infection. Viral Immunology 2016; 29(7): 401 doi: 10.1089/vim.2016.0008
57
Skender Topi, Elona Gaxhja, Ioannis Alexandros Charitos, Marica Colella, Luigi Santacroce. Hepatitis C Virus: History and Current Knowledge. Gastroenterology Insights 2024; 15(3): 676 doi: 10.3390/gastroent15030049
58
Sayan Poddar, Rajarshi Roy, Parimal Kar. The conformational dynamics of Hepatitis C Virus E2 glycoprotein with the increasing number of N -glycosylation unraveled by molecular dynamics simulations . Journal of Biomolecular Structure and Dynamics 2024; : 1 doi: 10.1080/07391102.2024.2319679
59
Sanket Mukherjee, Akhil Kumar, Jasmine Samal, Ekta Gupta, Perumal Vivekanandan, Manoj B. Menon. Selective Depletion of ZAP-Binding CpG Motifs in HCV Evolution. Pathogens 2022; 12(1): 43 doi: 10.3390/pathogens12010043
60
Pantazis I. Theotokis, Louise Usher, Christopher K. Kortschak, Ed Schwalbe, Sterghios A. Moschos. Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs. Molecular Therapy - Nucleic Acids 2017; 9: 22 doi: 10.1016/j.omtn.2017.08.010
61
Vincent Montoya, Anita Y. M. Howe, Weiyan Y. Dong, Winnie Dong, Chanson J. Brumme, Andrea D. Olmstead, Kanna Hayashi, P. Richard Harrigan, Jeffrey B. Joy. Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88132-8
62
Amina Gul, Nabeela Zahid, Jawad Ahmed, Fazli Zahir, Imtiaz Ali Khan, Ijaz Ali. Molecular characterization of Hepatitis C virus 3a in Peshawar. BMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1488-0
63
Guillermo A. Ortiz, Hirsh D. Trivedi, Claudia Nader. Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12648
64
Santseharay Ramirez, Jens Bukh. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies. Antiviral Research 2018; 158: 264 doi: 10.1016/j.antiviral.2018.07.014
65
Gokul Kalyanasundaram, James E. Feng, Frank Congiusta, Richard Iorio, Matthew DiCaprio, Afshin A. Anoushiravani. Treating Hepatitis C Before Total Knee Arthroplasty is Cost-Effective: A Markov Analysis. The Journal of Arthroplasty 2024; 39(2): 307 doi: 10.1016/j.arth.2023.08.053
66
Natalia Echeverría, Pilar Moreno, Juan Cristina. Human Virology in Latin America. 2017; : 333 doi: 10.1007/978-3-319-54567-7_17
67
Shivam Chowdhary, Rahul Deka, Kingshuk Panda, Rohit Kumar, Abhishikt David Solomon, Jimli Das, Supriya Kanoujiya, Ashish Kumar Gupta, Somya Sinha, Janne Ruokolainen, Kavindra Kumar Kesari, Piyush Kumar Gupta. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. Molecular Pharmaceutics 2023; 20(8): 3698 doi: 10.1021/acs.molpharmaceut.2c01080
68
Taiki Yamashita, Haruhiko Takeda, Atsushi Takai, Soichi Arasawa, Fumiyasu Nakamura, Yoichi Mashimo, Miyuki Hozan, Shigeru Ohtsuru, Hiroshi Seno, Yoshihide Ueda, Akihiro Sekine. Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genome. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59397-2
69
Moema S. Santana, Rute Lopes, Isabela H. Peron, Carla R. Cruz, Ana M.M. Gaspar, Paulo I. Costa. Natural Bioactive Compounds as Adjuvant Therapy for Hepatitis C Infection. Current Nutrition & Food Science 2021; 17(5): 458 doi: 10.2174/1573401316999201009152726
70
Geon-Woo Kim, Aleem Siddiqui. N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition. Proceedings of the National Academy of Sciences 2021; 118(10) doi: 10.1073/pnas.2022024118
71
Nadia Marascio, Salvatore Rotundo, Angela Quirino, Giovanni Matera, Maria Carla Liberto, Chiara Costa, Alessandro Russo, Enrico Maria Trecarichi, Carlo Torti. Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice . World Journal of Gastroenterology 2022; 28(12): 1226-1238 doi: 10.3748/wjg.v28.i12.1226
72
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
73
Anders Boyd, Léa Duchesne, Karine Lacombe. Research gaps in viral hepatitis. Journal of the International AIDS Society 2018; 21(S2) doi: 10.1002/jia2.25054
74
Jing Zhao, Ye Zhao, Guozhong Zhang. Key Aspects of Coronavirus Avian Infectious Bronchitis Virus. Pathogens 2023; 12(5): 698 doi: 10.3390/pathogens12050698
75
Svitlana I. Romaniuk, Serhiy V. Komisarenko. OW THE HEPATITIS C VIRUS WAS DISCOVERED, OR THE DETECTIVE SEARCHES OF VIROLOGISTS FOR THE SILENT KILLER. Visnik Nacional'noi' academii' nauk Ukrai'ni 2020; (12): 3 doi: 10.15407/visn2020.12.003
76
Hadas Dvory‐Sobol, Bin Han, Julia Lu, Mei Yu, Rudolf K. Beran, Guofeng Cheng, Ross Martin, Evguenia Svarovskaia, Hongmei Mo. In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. Journal of Viral Hepatitis 2019; 26(8): 991 doi: 10.1111/jvh.13116
77
Mohamed E. Ali, Hamada M. Halby, Mamdouh Yones Ali, Elham Ahmed Hassan, Mohamed A. El-Mokhtar, Ibrahim M. Sayed, Marwa M. Thabet, Magdy Fouad, Ahmed M. El-Ashmawy, Zainab Gaber Mahran. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents. Viruses 2021; 13(10): 2008 doi: 10.3390/v13102008
78
Nahla Fadl, Tamer Z. Salem. Hepatitis C genotype 4: A report on resistance‐associated substitutions in NS3, NS5A, and NS5B genes. Reviews in Medical Virology 2020; 30(4) doi: 10.1002/rmv.2120
79
Nobuyuki Kato. Hepatitis C virus (HCV)：Diversity and variation of RNA genome. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 2020; 132(2): 60 doi: 10.4044/joma.132.60
80
Christian Medina, Alexis Hipólito García, Francis Isamarg Crespo, Félix Isidro Toro, Soriuska José Mayora, Juan Bautista De Sanctis. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives. Current Issues in Molecular Biology 2023; 45(10): 8255 doi: 10.3390/cimb45100521
81
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines 2020; 8(1): 90 doi: 10.3390/vaccines8010090
82
Kaho H. Tisthammer, Caroline Solis, Faye Orcales, Madu Nzerem, Ryan Winstead, Weiyan Dong, Jeffrey B. Joy, Pleuni S. Pennings, Lindi Wahl. Assessing in vivo mutation frequencies and creating a high-resolution genome-wide map of fitness costs of Hepatitis C virus. PLOS Genetics 2022; 18(5): e1010179 doi: 10.1371/journal.pgen.1010179
83
Arun K. Bhunia. Foodborne Microbial Pathogens. Food Science Text Series 2018; : 133 doi: 10.1007/978-1-4939-7349-1_6
84
Sabina Velázquez-Márquez, Juan Núñez-Farfán. Pathogens Associated with the Development of Cancer in Humans. 2024; : 537 doi: 10.1007/978-3-031-62558-9_23
85
Julia Durzyńska, Anna Goździcka-Józefiak. Viruses and cells intertwined since the dawn of evolution. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0400-7
86
Darrick K. Li, Raymond T. Chung. Hepatitis C Virus Protocols. Methods in Molecular Biology 2019; 1911: 3 doi: 10.1007/978-1-4939-8976-8_1
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345